Prolonged Antiscarring Effects of Ilomastat and MMC after Experimental Glaucoma Filtration Surgery

Abstract

Ilomastat successfully prolongs bleb survival. MMP inhibition may provide an additional, potentially safer method of controlling intraocular pressure, thus preventing failure of glaucoma surgery, and may also act as a potential adjuvant treatment when MMC alone is inadequate.